Raytheon defense business drives quarterly profit beat

FAN Editor

Raytheon Technologies on Tuesday topped analysts’ estimates for quarterly profit and sales, boosted by strength in its defense business, which makes parts for Lockheed Martin’s F-35 fighter jets.

Continue Reading Below

Shares of the company rose 2.3% to $62.50 in premarket trading.

Raytheon said it achieved a record backlog of $73.1 billion from its defense business in the second quarter, pointing to strong demand from the U.S. government and international customers.

“This also points to how well our (defense) programs are funded and their alignment to the national defense strategy,” Raytheon Chief Financial Officer Toby O’Brien told Reuters.

ELON MUSK’S SPACEX BOOSTS US SATELLITE-BASED NAVIGATION

Raytheon gets about 30% of its defense sales from international customers.

The company said it continues to see full-year free cash flow of $2 billion, with its commercial aerospace business to be around break-even and defense business generating about $3.5 billion in cash by the end of the year.

CLICK HERE TO READ MORE ON FOX BUSINESS

The pandemic has extracted a heavy toll on the air industry, with Raytheon having warned last month it expects total commercial aero sales to be down about 50% between the second and fourth quarter.

Net loss attributable to common shareowners was $3.84 billion, or $2.55 per share, for the quarter ended June 30, compared with a profit of $1.90 billion, or $2.22 per share, a year earlier.

Ticker Security Last Change Change %
RTX RAYTHEON TECHNOLOGIES CORP 60.91 -0.18 -0.29%
LMT LOCKHEED MARTIN CORPORATION 387.57 +5.48 +1.43%

Revenue rose 24% to $14.06 billion, above estimates of $13.48 billion, according to Refinitiv data.

Excluding items, Raytheon earned 40 cents per share, above Street estimates of 12 cents per share.

Free America Network Articles

Leave a Reply

Next Post

Fauci says there are early signs coronavirus outbreaks are brewing in Ohio, Indiana, Kentucky and Tennessee

Director of the National Institute for Allergy and Infectious Diseases Dr. Anthony Fauci testifies before the House Committee on Energy and Commerce on the Trump Administration’s Response to the COVID-19 Pandemic, on Capitol Hill in Washington, DC, June 23, 2020. Kevin Dietsch | Pool via Reuters White House health advisor […]